Alambic Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-6,200
Closed -$393K 367
2018
Q1
$393K Sell
6,200
-5,350
-46% -$319K 0.05% 345
2017
Q4
$589K Sell
11,550
-350
-3% -$18.2K 0.07% 295
2017
Q3
$624K Hold
11,900
0.07% 324
2017
Q2
$606K Sell
11,900
-2,300
-16% -$114K 0.07% 346
2017
Q1
$631K Buy
14,200
+9,100
+178% +$391K 0.08% 358
2016
Q4
$225K Sell
5,100
-2,000
-28% -$85K 0.04% 482
2016
Q3
$284K Buy
7,100
+2,000
+39% +$84.9K 0.07% 382
2016
Q2
$243K Buy
+5,100
New +$216K 0.06% 412

Other funds holding CNMD

Alambic Investment Management's CNMD Position: Q2 2018 in Review

Alambic Investment Management sold out of CONMED (CNMD) in Q2 2018, closing a stake of 6,200 shares — an estimated $393K sold.

Alambic Investment Management first reported a position in CNMD in Q2 2016 and held it in 8 quarters. The position peaked at $631K in Q1 2017. 196 funds tracked by Wall St. Rank hold CNMD as of Q2 2018.

  • Alambic Investment Management reported no remaining CONMED position as of Q2 2018 after selling out during the quarter.
  • Alambic Investment Management sold 6,200 CONMED shares in Q2 2018, an estimated $393K.
  • Alambic Investment Management first reported a position in CONMED in Q2 2016 and held it in 8 quarters.
  • Alambic Investment Management's CONMED position peaked at $631K in Q1 2017.
  • 196 funds tracked by Wall St. Rank held CONMED as of Q2 2018.

Based on Alambic Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.